Investigational Monoclonal Antibodies in the Treatment of Multiple Myeloma: A Systematic Review of Agents under Clinical Development

Background: Immunotherapy for multiple myeloma (MM) has been the focus in recent years due to its myeloma-specific immune responses. We reviewed the literature on non-Food and Drug Administration (FDA) approved monoclonal antibodies (mAbs) to highlight future perspectives. We searched PubMed, EMBASE...

Descripción completa

Detalles Bibliográficos
Autores principales: Iftikhar, Ahmad, Hassan, Hamza, Iftikhar, Nimra, Mushtaq, Adeela, Sohail, Atif, Rosko, Nathaniel, Chakraborty, Rajshekhar, Razzaq, Faryal, Sandeep, Sonia, Valent, Jason Neil, Kanate, Abraham Sebastian, Anwer, Faiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640719/
https://www.ncbi.nlm.nih.gov/pubmed/31544840
http://dx.doi.org/10.3390/antib8020034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640719/
https://www.ncbi.nlm.nih.gov/pubmed/31544840
http://dx.doi.org/10.3390/antib8020034

Ejemplares similares